Molbio Diagnostics shareholders and shareholding pattern
NSE: MOLBIOBSE: 544866Healthcare Equipment & Supplies
Last close ₹1,239.10down ₹20.60 (1.64%)BSE ₹1,237.65
Share price at the NSE close on 23 Oct 2026. Previous close ₹1,259.70.
Range of traded prices from listing on 17 Aug 2026 to 23 Oct 2026
₹926.35Low, 17 Aug 2026₹1,686.80High, 11 Sep 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price.
- ₹14,279 Cr
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- No full year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet.
- No balance sheet
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonesince listing in Aug 2026
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 13,05,45320.6% delivered
Who owns Molbio Diagnostics, filing by filing
Per cent of the company's shares. Every filing on record, from Sep 2026; the latest is the filing for Sep 2026.
Sep 2026 filing
- Promoters41.29%
- Foreign institutions1.59%
- Indian institutions19.08%
- Individuals and others38.03%
| Per cent | Sep 2026Filed 15 Oct |
|---|---|
| 41.29% | |
| Indian promoters | 41.29% |
| Public. Every shareholder outside the promoter group, the employee trusts and the shares held against depositary receipts, as the filing totals them. | 58.71% |
| Shares in issue | 11,52,39,996 |
| Shares locked inShares locked in. Shares the filing reports as barred from sale until a set day, such as promoters' shares after a public issue or shares allotted to an investor directly. | 9,20,60,861 |
| Promoters' shares locked in | 4,75,82,801 |
A dash is a line the filing did not state.
Molbio Diagnostics promoters
Promoters are the founders, families and companies that control the company, as its filings name them. Every member of the promoter group holding shares in the filing for Sep 2026; the largest is EXXORA TRADING LLP, 37.05%. The filing names 41 more members with no shares.
| Holder | |||
|---|---|---|---|
| EXXORA TRADING LLPIndian companies, trusts and others | 37.05% | 4,26,93,951 | 100.00% |
| Chandrasekhar Bhaskaran NairIndividuals and Hindu undivided families | 4.24% | 48,88,850 | 100.00% |
No promoter shares are reported as pledged. Locked in is the share of the holder's own shares that cannot be sold yet, as after a listing or an allotment.
Molbio Diagnostics lock-in dates
At listing on 17 Aug 2026, 81.4% of the shares were locked in; the rest were free to sell from that day.
| Free to sell fromShares locked in. Shares the rules for a public issue bar from being sold until a set day: the promoters' and the anchor investors' shares, and the shares held before the issue. | Shares | Of all shares |
|---|---|---|
| 11 Sep 2026 | 17,43,856 | 1.51% |
| 10 Nov 2026 | 17,43,861 | 1.51% |
| 4 Feb 2027 | 4,95,661 | 0.43% |
| 13 Feb 2027 | 4,22,38,538 | 36.65% |
| 13 Aug 2027 | 2,45,34,701 | 21.29% |
| 13 Aug 2029 | 2,30,48,100 | 20.00% |
Each day a lock ends and the shares it frees, as a share of all the company's shares after the issue.
Largest public holders of Molbio Diagnostics, filing by filing
Per cent, on the same shares as the split above.Mutual funds holding Molbio Diagnostics
| Holder | Sep 2026Filed 15 Oct |
|---|---|
| BUSINESS EXCELLENCE TRUST III - INDIA BUSINESS EXCAlternative investment funds | 8.92% |
| V-SCIENCES INVESTMENTS PTE LTDForeign companies | 8.74% |
| KINI GOPALKRISHNA MANGALOREResident individuals, over ₹2 lakh at face value | 5.61% |
| GOPALAKRISHNA SAMPATHGIRIResident individuals, over ₹2 lakh at face value | 4.52% |
| JAVAGAL GURU DUTTResident individuals, over ₹2 lakh at face value | 4.48% |
| USHA RANI M AResident individuals, over ₹2 lakh at face value | 2.45% |
| SANGEETHA MANGALORE KINIResident individuals, over ₹2 lakh at face value | 2.26% |
| ROHIT MULLANGI ASHOK KUMARResident individuals, over ₹2 lakh at face value | 1.45% |
| SHRUTHI G KININon-resident Indians | 1.09% |
A filing names every holder above one per cent, in the company's own words: an insurer's holding can carry one of its funds' names. Mutual funds are left out here: each fund's holding is on the Mutual funds tab, from its own portfolio. A dash is a filing that did not name the holder, which includes holding under one per cent.